Marten J. Poley - Erasmus Universiteit Rotterdam

More documents

Recommendations

Info

86Chapter 568. Hui TT, Danielson PD, Anderson KD,Stein JE: The impact of changingneonatal respiratory management onextracorporeal membrane oxygenationutilization. J Pediatr Surg 2002; 37(5):703-705.69. Arensman RM, Statter MB, BastawrousAL, Madonna MB: Modern treatmentmodalities for neonatal and pediatricrespiratory failure. Am J Surg 1996;172(1): 41-47.70. Cornish JD: The changing pattern ofneonatal ECMO. Do we really need it? InTibboel D, Voort Evd (eds): Intensivecare in childhood: a challenge to thefuture (Update in intensive care andemergency medicine; 25). Berlin:Springer-Verlag; 1996.71. McGettigan MC, Adolph VR, GinsbergHG, Goldsmith JP: New ways to ventilatenewborns in acute respiratory failure.Pediatr Clin North Am 1998; 45(3): 475-509.72. Schumacher RE: Extracorporealmembrane oxygenation. Will thistherapy continue to be as efficacious inthe future? Pediatr Clin North Am 1993;40(5): 1005-1022.73. Goddard-Finegold J: Neurologicaloutcome after extracorporeal membraneoxygenation therapy in the newborn. InWright LL (eds): Report of the workshopon diffusion of ECMO technology. NIHpublication no. 93-3399. Washington,D.C.: U.S. Department of Health andHuman Services; 1993.74. Rais-Bahrami K, Wagner AE, Coffman C,Glass P, Short BL: Neurodevelopmentaloutcome in ECMO vs near-miss ECMOpatients at 5 years of age. Clin Pediatr(Phila) 2000; 39(3): 145-152.76. Bennett CC, Johnson A, Field DJ,Elbourne D: UK collaborative randomisedtrial of neonatal extracorporealmembrane oxygenation: follow-up toage 4 years. Lancet 2001; 357(9262):1094-1096.77. Bernbaum J, Schwartz IP, Gerdes M,D'Agostino JA, Coburn CE, Polin RA:Survivors of extracorporeal membraneoxygenation at 1 year of age: therelationship of primary diagnosis withhealth and neurodevelopmentalsequelae. Pediatrics 1995; 96(5): 907-913.78. Jaillard S, Pierrat V, Truffert P, Métois D,Riou Y, Wurtz A, et al: Two years' followupof newborn infants afterextracorporeal membrane oxygenation(ECMO). Eur J Cardiothorac Surg 2000;18(3): 328-333.79. Wilson IB, Cleary PD: Linking clinicalvariables with health-related quality oflife. A conceptual model of patientoutcomes. JAMA 1995; 273(1): 59-65.80. Davis PJ, Firmin RK, Manktelow B,Goldman AP, Davis CF, Smith JH, et al:Long-term outcome followingextracorporeal membrane oxygenationfor congenital diaphragmatic hernia: theUK experience. J Pediatr 2004; 144(3):309-315.81. Glass P, Wagner AE, Papero PH,Rajasingham SR, Civitello LA, Kjaer MS,et al: Neurodevelopmental status at agefive years of neonates treated withextracorporeal membrane oxygenation. JPediatr 1995; 127(3): 447-457.82. Kanto WP, Bunyapen C: Extracorporealmembrane oxygenation. Controversies inselection of patients and management.Clin Perinatol 1998; 25(1): 123-135.75. Beardsmore C, Dundas I, Poole K, EnockK, Stocks J: Respiratory function insurvivors of the United KingdomExtracorporeal Membrane OxygenationTrial. Am J Respir Crit Care Med 2000;161(4 Pt 1): 1129-1135.
INFORMAL CARE FORCHILDREN BORN WITHMAJOR CONGENITALANOMALIES: WHAT DOESIT ASK AND WHAT DOESIT DO TO PARENTS'HEALTH-RELATEDQUALITY OF LIFE?
Page 3:
COST-EFFECTIVENESS OF NEONATAL SURG
Page 6 and 7:
DOCTORAL COMMITTEEPromotors:Prof.dr
Page 9 and 10:
PUBLICATIONSChapters 2 to 7 are bas
Page 11:
6ChapterINFORMAL CARE FOR CHILDREN
Page 14 and 15:
2Chapter 11.1 BACKGROUND AND MOTIVA
Page 16 and 17:
4Chapter 1provides a good overview
Page 18 and 19:
6Chapter 1disability, and death of
Page 21:
Introduction 9particular equity pri
Page 25 and 26:
Introduction 1320. Oostenbrink JB,
Page 27 and 28:
Introduction 1554. Heyman MB, Harma
Page 29 and 30:
THE COST-EFFECTIVENESS OFTREATMENT
Page 31:
Cost-Effectiveness of Treatment for
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45:
Page 48 and 49: 36Chapter 3ABSTRACTBackground/Purpo
Page 50 and 51: 38Chapter 33.2 MATERIALS AND METHOD
Page 52 and 53: 40Chapter 3child's date of birth) a
Page 54 and 55: 42Chapter 3diaphragm was closed (Ta
Page 56 and 57: 44Chapter 3Total costs of treatment
Page 58 and 59: 46Chapter 3Regarding the treatment
Page 60 and 61: 48Chapter 3REFERENCES1. Stolk EA, P
Page 62 and 63: 50Chapter 332. Jaillard S, Pierrat
Page 64 and 65: 52Chapter 4ABSTRACTAims:To examine
Page 66 and 67: 54Chapter 4Outcome measuresThe pati
Page 68 and 69: 56Chapter 4Clearly, the symptoms st
Page 70 and 71: 58Chapter 4The respondents did not
Page 72 and 73: 60Chapter 4Table 4.4TAIQOL Scores o
Page 74 and 75: 62Chapter 44.4 DISCUSSIONIn this pa
Page 76 and 77: 64Chapter 4ACKNOWLEDGMENTSWe are in
Page 78 and 79: 66Chapter 418. Coons SJ, Rao S, Kei
Page 80 and 81: 68Chapter 5ABSTRACTObjective:Extrac
Page 82 and 83: 70Chapter 5treatment. 26,27 Finally
Page 84 and 85: 72Chapter 5CostsOnly direct costs w
Page 86 and 87: 74Chapter 5summarized in Table 5.2.
Page 88 and 89: 76Chapter 5Table 5.3 Direct Medical
Page 90 and 91: 78Chapter 5Figure 5.3 illustrates o
Page 92 and 93: 80Chapter 5severely ill newborns—
Page 94 and 95: 82Chapter 5REFERENCES1. Bartlett RH
Page 96 and 97: 84Chapter 533. Meinert CL: Extracor
Page 100 and 101: 88Chapter 6ABSTRACTObjective:To inv
Page 102 and 103: 90Chapter 6a rule. The health-relat
Page 104 and 105: 92Chapter 6Regression analysis of h
Page 106 and 107: 94Chapter 6that caregiving for thei
Page 108 and 109: 96Chapter 6Table 6.5 CareQol Compar
Page 110 and 111: 98Chapter 6children with a disabili
Page 112 and 113: 100Chapter 6This study was of impor
Page 114 and 115: 102Chapter 618. Poley MJ, Stolk EA,
Page 116 and 117: 104Chapter 654. Boman KK, Viksten J
Page 118 and 119: 106Chapter 7ABSTRACTMortality rates
Page 120 and 121: 108Chapter 77.2 THE RELEVANCE OF CO
Page 122 and 123: 110Chapter 7In the early 2000s, our
Page 124 and 125: 112Chapter 7Table 7.1 Economic Eval
Page 126 and 127: 114Chapter 7More from a policy pers
Page 128 and 129: 116Chapter 7also expect that life-s
Page 130 and 131: 118Chapter 7entirely justified, for
Page 132 and 133: 120Chapter 723. Sydorak RM, Nijagal
Page 134 and 135: 122Chapter 765. Glaser AW, Davies K
Page 137 and 138: GENERAL DISCUSSION:A GUIDED TOURPRO
Page 139 and 140: General Discussion: A Guided Tour P
Page 149 and 150:
General Discussion: A Guided Tour P
Page 151:
General Discussion: A Guided Tour P
Page 154 and 155:
142GlossaryCharge (or: tariff)A pri
Page 156 and 157:
144Glossaryefficient one. We are th
Page 159 and 160:
SUMMARY
Page 161 and 162:
Summary 149mortality. Finally, it i
Page 163 and 164:
Summary 151neonatal surgery. It is
Page 165 and 166:
SAMENVATTING
Page 167 and 168:
Samenvatting 155zoals directe niet-
Page 169 and 170:
Samenvatting 157Hoofdstuk 6 gaat ve
Page 171:
Samenvatting 159vereisen, waarvoor
Page 174 and 175:
162AcknowledgmentsAlthough I am ind
Page 176:
About the AuthorBorn in De Meern (N
show all

Marten J. Poley - Erasmus Universiteit Rotterdam

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?